{
    "rcn": "207143",
    "acronym": "OSCANN",
    "topics": "SMEInst-06-2016-2017",
    "title": "Diagnosing platform for neurological and mental disorders based on the analysis of ocular and oculocephalic movements.",
    "startDate": "01/01/2017",
    "endDate": "30/06/2017",
    "objective": "The first product that AURA will launch to the market will be OSCANN, a diagnosis platform that will allow better, faster\nand more accurate diagnosis of neurological disorders affecting Europe√≠s population in general, but specially youngsters\n(e.g. ADHD) and elders (e.g. Parkinson). OSCANN allows for the measurement and analysis of ocular and oculocephalic\nmovements (OM/OCM) and combines the result with data obtained from other sources (clinical histories, medical\nexplorations, complementary tests and biomarkers) using Artificial Intelligence (AI) techniques to improve significantly the\nquality of medical diagnosis in early stages.",
    "totalCost": "71429",
    "ecMaxContribution": "50000",
    "coordinator": "AURA INNOVATIVE ROBOTICS, SL",
    "coordinatorCountry": "ES",
    "participants": "",
    "participantCountries": "",
    "projectParticipants": {
        "927215241": {
            "orgId": "927215241",
            "orgName": "AURA INNOVATIVE ROBOTICS, SL",
            "ecContrib": 50000
        }
    },
    "calculatedTotalContribution": 50000
}